Elevation of IL-18 in human sepsis

Citation
Sr. Grobmyer et al., Elevation of IL-18 in human sepsis, J CLIN IMM, 20(3), 2000, pp. 212-215
Citations number
19
Categorie Soggetti
Immunology
Journal title
JOURNAL OF CLINICAL IMMUNOLOGY
ISSN journal
02719142 → ACNP
Volume
20
Issue
3
Year of publication
2000
Pages
212 - 215
Database
ISI
SICI code
0271-9142(200005)20:3<212:EOIIHS>2.0.ZU;2-B
Abstract
Interleukin-18 (IL-18) is a recently identified immunoregulatory cytokine t hat shares biochemical features with IL-1 beta and acts in part by inducing interferon-gamma (IFN-gamma). Endotoxic bacterial lipopolysaccharide (LPS) (1 or 2 ng/kg) was insufficient to increase plasma IL-18 in five healthy a dults measured 3, 12, and 24 hr following challenge. In contrast, in the fi rst 96 hr of admission to the surgical intensive carl unit, mean maximal se rum IL-18 was elevated(1122 +/- 259 pg/ml) in nine septic patients compared to six healthy adults (191 +/- 42, pg/ml), P < 0.01). Serum IL-18 concentr ations in septic patients did not correlate with other measured inflammator y mediators: tumor necrosis factor, IL-6, IL-10, or secretory leukocyte pro tease inhibitor. Therefore, IL-18 circulates in healthy adults and is a com ponent of the human systemic inflammatory response. Further, stimuli other than LPS may induce IL-18 production in vivo in human sepsis.